Tom Cohen

Absci to Collaborate with the Memorial Sloan Kettering Cancer Center to Develop Biologics using AI

—

by

Tom Cohen
in

The two organisations will work side by side on up to six programmes which will develop new cancer drug candidates using AI.

Read More

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *